← Back to Search

Multifocal Contact Lenses for Accommodation Disorder

N/A
Recruiting
Led By Ann M Morrison, OD, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No history of ocular disease or active ocular inflammation
Free of binocular vision disorder (strabismus, amblyopia, vergence dysfunction, accommodative dysfunction)
Must not have
No prior or concurrent participation in myopia control or use of low dose atropine, multifocal contact lenses
No use of any medications suspected to affect accommodation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to two hours
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine how soft multifocal contact lenses affect presbyopic vision and accommodative & binocular vision disorders. They are designed to provide a range of clear vision at both distance and near by introducing a power gradient over the eye. Results will help us understand if center near designs provide a greater therapeutic effect for these disorders.

Who is the study for?
This trial is for individuals aged 18 to 30 with good vision (20/25 or better) in both eyes using their current contact lenses. They should have no eye diseases, surgeries, rigid lens wear, significant astigmatism (>1.00 D), or binocular vision disorders. Participants must not be on treatments affecting myopia control or accommodation.
What is being tested?
The study tests how center near and center distance multifocal contact lenses affect accommodative function in young adults. It aims to determine if these lenses can help manage issues like difficulty focusing on close objects by comparing the effectiveness of different lens designs.
What are the potential side effects?
While the trial doesn't explicitly mention side effects, typical ones from wearing contact lenses may include eye discomfort, dryness, redness, blurred vision, and a feeling of something in the eye.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have no history of eye diseases or current eye inflammation.
Select...
I do not have any disorders affecting my ability to see clearly with both eyes.
Select...
I have never had eye surgery.
Select...
I am between 18 and 30 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not used treatments like low dose atropine or multifocal lenses for myopia control.
Select...
I am not taking any medications that could affect my eyesight.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to two hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Objective Accommodative Outcome
Secondary study objectives
Accommodation Clinical Measures
Vergence Clinical Measures

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Center Near Multifocal Contact LensExperimental Treatment1 Intervention
All participants will wear a Biofinity center near multifocal contact lens with a +2.50 add and measurements will be obtained.
Group II: Center Distance Multifocal Contact LensExperimental Treatment1 Intervention
All participants will wear a Biofinity center distance multifocal contact lens with a +2.50 add and measurements will be obtained.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,137 Total Patients Enrolled
Ann M Morrison, OD, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
35 Total Patients Enrolled
~2 spots leftby Dec 2024